Suppr超能文献

瑞士第二原发癌的相对风险:一项基于人群的回顾性队列研究。

The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study.

机构信息

Foundation National Institute for Cancer Epidemiology and Registration (NICER), University of Zurich, Zurich, Switzerland.

Cancer Registry Zurich and Zug, University Hospital Zurich, Zurich, Switzerland.

出版信息

BMC Cancer. 2020 Jan 21;20(1):51. doi: 10.1186/s12885-019-6452-0.

Abstract

BACKGROUND

More people than ever before are currently living with a diagnosis of cancer and the number of people concerned is likely to continue to rise. Cancer survivors are at risk of developing a second primary cancer (SPC). This study aims to investigate the risk of SPC in Switzerland.

METHODS

The study cohort included all patients with a first primary cancer recorded in 9 Swiss population-based cancer registries 1981-2009 who had a minimum survival of 6 months, and a potential follow-up until the end of 2014. We calculated standardized incidence ratios (SIR) to estimate relative risks (RR) of SPC in cancer survivors compared with the cancer risk of the general population. SIR were stratified by type of first cancer, sex, age and period of first diagnosis, survival period and site of SPC.

RESULTS

A total of 33,793 SPC were observed in 310,113 cancer patients. Both male (SIR 1.18, 95%CI 1.16-1.19) and female (SIR 1.20, 95%CI 1.18-1.22) cancer survivors had an elevated risk of developing a SPC. Risk estimates varied substantially according to type of first cancer and were highest in patients initially diagnosed with cancer of the oral cavity and pharynx, Hodgkin lymphoma, laryngeal, oesophageal, or lung cancer. Age-stratified analyses revealed a tendency towards higher RR in patients first diagnosed at younger ages. Stratified by survival period, risk estimates showed a rising trend with increasing time from the initial diagnosis. We observed strong associations between particular types of first and SPC, i.e. cancer types sharing common risk factors such as smoking or alcohol consumption (e.g. repeated cancer of the oral cavity and pharynx (SIR 20.12, 95%CI 17.91-22.33; SIR 37.87, 95%CI 30.27-45.48).

CONCLUSION

Swiss cancer survivors have an increased risk of developing a SPC compared to the general population, particularly patients first diagnosed before age 50 and those surviving more than 10 years. Cancer patients should remain under continued surveillance not only for recurrent cancers but also for new cancers. Some first and SPCs share lifestyle associated risk factors making it important to promote healthier lifestyles in both the general population and cancer survivors.

摘要

背景

目前,比以往任何时候都有更多的人被诊断出患有癌症,而且这个数字可能还会继续上升。癌症幸存者有发展第二原发癌(SPC)的风险。本研究旨在调查瑞士 SPC 的风险。

方法

研究队列包括 1981 年至 2009 年在瑞士 9 个基于人群的癌症登记处记录的首次原发性癌症患者,这些患者的最低生存时间至少为 6 个月,潜在随访时间截止至 2014 年底。我们计算标准化发病比(SIR)来估计癌症幸存者 SPC 的相对风险(RR)与普通人群的癌症风险相比。SIR 按首次癌症类型、性别、年龄和首次诊断时期、生存时间和 SPC 部位进行分层。

结果

在 310113 名癌症患者中观察到 33793 例 SPC。男性(SIR 1.18,95%CI 1.16-1.19)和女性(SIR 1.20,95%CI 1.18-1.22)癌症幸存者都有发展 SPC 的风险增加。风险估计根据首次癌症的类型而有很大差异,最初诊断为口腔和咽部癌症、霍奇金淋巴瘤、喉癌、食管癌或肺癌的患者风险最高。年龄分层分析显示,首次诊断年龄较小的患者 RR 更高。按生存时间分层,风险估计随着从初始诊断时间的增加而呈上升趋势。我们观察到特定类型的首次癌症和 SPC 之间存在很强的关联,即具有共同风险因素的癌症类型,例如吸烟或饮酒(例如,口腔和咽部的复发性癌症(SIR 20.12,95%CI 17.91-22.33;SIR 37.87,95%CI 30.27-45.48)。

结论

与普通人群相比,瑞士癌症幸存者发生 SPC 的风险增加,尤其是首次诊断年龄小于 50 岁和生存时间超过 10 年的患者。癌症患者不仅应继续监测复发癌症,还应监测新发癌症。一些首次癌症和 SPC 具有与生活方式相关的共同风险因素,因此重要的是促进普通人群和癌症幸存者的更健康生活方式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1204/6974968/738b127e5d63/12885_2019_6452_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验